Filing Analysis
Outset Medical entered into a 'Refresh Amendment' with HCA Management Services, L.P. to update HCA's existing fleet of Tablo Hemodialysis Systems with new units between 2026 and 2028.
📋 Key Facts
- Aggregate contract value for the refresh is approximately $40 million, net of rebates and allowances.
- The agreement spans from 2026 through the end of 2028.
- The amendment includes a framework for console and consumables purchases to support future growth within HCA hospitals.
- The company is reiterating its previously issued 2026 guidance.
Outset Medical reported the results of its 2026 Annual Meeting of Stockholders held on June 4, 2026. The company successfully elected two Class III directors, approved executive compensation on an advisory basis, and ratified the appointment of KPMG LLP as its independent auditor.
📋 Key Facts
- Annual Meeting held on June 4, 2026, with a quorum of 13,890,864 shares present out of 18,529,233 outstanding.
- Brent D. Lang and Karen Prange were elected as Class III directors for terms ending in 2029.
- The 2025 compensation for named executive officers was approved on a non-binding advisory basis (7,548,774 For vs 3,196,870 Against).
- KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Outset Medical, Inc. announced that Marc Nash, Executive Vice President of R&D, Operations and Service, will depart the company effective June 5, 2026, to pursue other professional opportunities.
🚩 Red Flags
- Loss of a key executive overseeing three critical functions simultaneously: R&D, Operations, and Service
📋 Key Facts
- Executive departing: Marc Nash
- Role: Executive Vice President, R&D, Operations and Service
- Departure date: June 5, 2026
- Reason provided: To pursue other professional opportunities
- Company states the departure is not due to any dispute or disagreement with management
Outset Medical, Inc. announced its financial results for the first quarter ended March 31, 2026. The company furnished a press release and scheduled an earnings conference call to discuss the results.
📋 Key Facts
- The filing reports financial results for the first quarter ended March 31, 2026.
- The report was filed on May 7, 2026, under Item 2.02 (Results of Operations and Financial Condition).
- A press release titled 'Outset Medical Reports First-Quarter Results' was included as Exhibit 99.1.
- The report was signed by Renee Gaeta, Chief Financial Officer.